BIOMARIN PHARMACEUTICAL INC.
Develops and commercializes biopharmaceuticals.
- Active Clients
- 1
- TTM Spend
- $1,260,000
- Total Filings
- 54
- Active Since
- 2013
trailing 4 reported quarters
income + expenses, last 12mo
5 in the last 12 months
14 years with filings
Income & Lobbyist Activity Last 10 years, by quarter
Clients from the last four reported quarters (1) · ranked by reported income and expenses
| Client | Reported $ | Filings | Share |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | $1.26M | 5 | 100.0% |
Issues lobbied last four reported quarters
| Issue | Activities | Share |
|---|---|---|
HCR
Health Issues
|
5 | 25.0% |
MMM
Medicare/Medicaid
|
5 | 25.0% |
TAR
Tariff (miscellaneous tariff bills)
|
5 | 25.0% |
MED
Medical/Disease Research/Clinical Labs
|
3 | 15.0% |
BUD
Budget/Appropriations
|
1 | 5.0% |
TAX
Taxation/Internal Revenue Code
|
1 | 5.0% |
Government entities contacted last four reported quarters
| Entity | Contacts | Share | Type |
|---|---|---|---|
| HOUSE OF REPRESENTATIVES | 20 | 42.6% | Congress |
| SENATE | 14 | 29.8% | Congress |
| Health & Human Services, Dept of (HHS) | 5 | 10.6% | Agency |
| Health Resources & Services Administration (HRSA) | 3 | 6.4% | Agency |
| Commerce, Dept of (DOC) | 2 | 4.3% | Agency |
| Food & Drug Administration (FDA) | 2 | 4.3% | Agency |
| Executive Office of the President (EOP) | 1 | 2.1% | Agency |
Revolving door lobbyists active in the last 12 months
1 of 3 lobbyists (33%) listed a prior covered government position on a lobbying filing.
- DANIEL MAYNE
- SENIOR REGULATORY HEALTH CONSULTANT- FOOD & DRUG ADMINISTRATION (6/2020-2/2022); REGULATORY POLICY ANALYST- FOOD & DRUG ADMINISTRATION (9/2023-6/2024)
Political contributions semiannual LD-203 reports by the firm and its lobbyists
3 reports on file for 2025 (latest version of each); 0 reported no contributions.
Itemized by year
| Year | Items | Total |
|---|---|---|
| 2025 | 4 | $6,500 |
Largest recipients, 2025
| Recipient | Items | Total |
|---|---|---|
| DAN CRENSHAW FOR CONGRESS honoring REP. DAN CRENSHAW | 1 | $2,500 |
| PFLUGER VICTORY COMMITTEE honoring REP. AUGUST PFLUGER | 1 | $2,500 |
| BUDDY CARTER FOR SENATE honoring REP. BUDDY CARTER, CANDIDATE, U.S. SENATE | 1 | $1,000 |
| JAKE AUCHINCLOSS FOR CONGRESS honoring REP. JAKE AUCHINCLOSS | 1 | $500 |
Filings 54 total
| Posted | Period | Client | Type | Income | Expenses | Activities | Lobbyists |
|---|---|---|---|---|---|---|---|
| 2026-07-20 | 2026 Q2 | BIOMARIN PHARMACEUTICAL INC. | 2nd Quarter - Amendment |
— | $340.0K | 4 | 3 |
| 2026-07-20 | 2026 Q2 | BIOMARIN PHARMACEUTICAL INC. | 2nd Quarter - Amendment |
— | $340.0K | 4 | 3 |
| 2026-07-20 | 2026 Q2 | BIOMARIN PHARMACEUTICAL INC. | 2nd Quarter - Report |
— | $340.0K | 4 | 3 |
| 2026-04-20 | 2026 Q1 | BIOMARIN PHARMACEUTICAL INC. | 1st Quarter - Report |
— | $530.0K | 3 | 2 |
| 2026-01-21 | 2025 Q4 | BIOMARIN PHARMACEUTICAL INC. | 4th Quarter - Report |
— | $390.0K | 5 | 2 |
| 2025-10-20 | 2025 Q3 | BIOMARIN PHARMACEUTICAL INC. | 3rd Quarter - Report |
— | $270.0K | 5 | 2 |
| 2025-07-21 | 2025 Q2 | BIOMARIN PHARMACEUTICAL INC. | 2nd Quarter - Report |
— | $270.0K | 4 | 2 |
| 2025-04-21 | 2025 Q1 | BIOMARIN PHARMACEUTICAL INC. | 1st Quarter - Report |
— | $390.0K | 4 | 2 |
| 2025-01-21 | 2024 Q4 | BIOMARIN PHARMACEUTICAL INC. | 4th Quarter - Report |
— | $490.0K | 2 | 2 |
| 2024-10-21 | 2024 Q3 | BIOMARIN PHARMACEUTICAL INC. | 3rd Quarter - Report |
— | $240.0K | 2 | 2 |
Lobbyists active in the last 12 months (3)
- JOHN GREISSING
- KATHRYN LOWELL
- DANIEL MAYNE · prior govt